[
  {
    "ts": "2025-09-17T21:50:05+00:00",
    "headline": "Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors",
    "summary": "In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $387.15, denoting a -1.08% move from the preceding trading day.",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-declines-more-215005142.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "25cfb0cf-51af-3ef6-9471-73c5ae6dfca7",
      "content": {
        "id": "25cfb0cf-51af-3ef6-9471-73c5ae6dfca7",
        "contentType": "STORY",
        "title": "Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors",
        "description": "",
        "summary": "In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $387.15, denoting a -1.08% move from the preceding trading day.",
        "pubDate": "2025-09-17T21:50:05Z",
        "displayTime": "2025-09-17T21:50:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248",
          "originalWidth": 900,
          "originalHeight": 467,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EqfP7bv9QEr5Eo0h619oww--~B/aD00Njc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 900,
              "height": 467,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vJLygzZiYik0.mXQcVdmSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b95cfdd8768bc3c4620e666dbcb0b248.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-declines-more-215005142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-declines-more-215005142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-17T14:00:00+00:00",
    "headline": "2 Growth Stocks to Buy and Hold Forever",
    "summary": "Look beyond the recent headwinds these two have faced.",
    "url": "https://www.fool.com/investing/2025/09/17/2-growth-stocks-to-buy-and-hold-forever/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "be774228-f7ba-389a-b10e-fe4112bd5282",
      "content": {
        "id": "be774228-f7ba-389a-b10e-fe4112bd5282",
        "contentType": "STORY",
        "title": "2 Growth Stocks to Buy and Hold Forever",
        "description": "",
        "summary": "Look beyond the recent headwinds these two have faced.",
        "pubDate": "2025-09-17T14:00:00Z",
        "displayTime": "2025-09-17T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/63b283c200de87b7a2f6859de23e7af2",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Physicians performing an operation.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hC0ZmD8yG.aLoRxCWkVoAA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/63b283c200de87b7a2f6859de23e7af2.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zrUimkgAKqecTqx10_Nhig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/63b283c200de87b7a2f6859de23e7af2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/09/17/2-growth-stocks-to-buy-and-hold-forever/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-growth-stocks-buy-hold-140000555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-17T13:28:00+00:00",
    "headline": "Vertex Plunges Around 24% in Six Months: How to Play the Stock",
    "summary": "Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.",
    "url": "https://finance.yahoo.com/news/vertex-plunges-around-24-six-132800097.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "adead8dc-a28c-3e72-866b-9d9167cb7f04",
      "content": {
        "id": "adead8dc-a28c-3e72-866b-9d9167cb7f04",
        "contentType": "STORY",
        "title": "Vertex Plunges Around 24% in Six Months: How to Play the Stock",
        "description": "",
        "summary": "Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.",
        "pubDate": "2025-09-17T13:28:00Z",
        "displayTime": "2025-09-17T13:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/54CAf0a.xcVnm138kMlg2g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qq8AX6cTgCCg_4Ye3FJ4Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-plunges-around-24-six-132800097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-plunges-around-24-six-132800097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-17T11:41:28+00:00",
    "headline": "How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025",
    "summary": "If you have been eyeing Vertex Pharmaceuticals and wondering whether it is the right time to buy, sell, or simply hold tight, you are far from alone. Vertex has been on a journey, sometimes up, sometimes down, which has kept investors on their toes. Over the past year, the stock fell 18.7%, a move that might make some skittish, while longer-term holders can still point to impressive gains of 36.4% over three years and 46.3% over five. Shorter-term numbers, like the -1.3% seven-day return and...",
    "url": "https://finance.yahoo.com/news/recent-fda-approval-impacts-valuation-114128390.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0a037ea2-168f-3d2c-b3af-da8f7d2b5ba0",
      "content": {
        "id": "0a037ea2-168f-3d2c-b3af-da8f7d2b5ba0",
        "contentType": "STORY",
        "title": "How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025",
        "description": "",
        "summary": "If you have been eyeing Vertex Pharmaceuticals and wondering whether it is the right time to buy, sell, or simply hold tight, you are far from alone. Vertex has been on a journey, sometimes up, sometimes down, which has kept investors on their toes. Over the past year, the stock fell 18.7%, a move that might make some skittish, while longer-term holders can still point to impressive gains of 36.4% over three years and 46.3% over five. Shorter-term numbers, like the -1.3% seven-day return and...",
        "pubDate": "2025-09-17T11:41:28Z",
        "displayTime": "2025-09-17T11:41:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-fda-approval-impacts-valuation-114128390.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-fda-approval-impacts-valuation-114128390.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]